Merck Serono S.A. v. Hopewell Pharma Ventures, Inc.
CAFC Affirms Obviousness-Type Double Patenting Invalidity of Merck MS Drug Patent
cafc · 2025-10-30 · Defendant Win · Impact: 40/100
Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., decided by Federal Circuit on October 30, 2025, resulted in a defendant win outcome. The core dispute involved Merck's claim that Hopewell infringe...